6,7-Dihydroxy-3,4-Dihydroisoquinoline: A Novel Inhibitor of Nuclear Factor-κB and in vitro Invasion in Murine Mammary Cancer Cells

Publisher： Karger

E-ISSN： 1421-9794|55|3|175-182

ISSN： 0009-3157

Source： Chemotherapy, Vol.55, Iss.3, 2009-04, pp. : 175-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of Baicalin on the Expression of Receptor Activator of Nuclear Factor-κB Ligand in Cultured Human Periodontal Ligament Cells

By  

Pharmacology, Vol. 77, Iss. 2, 2006-06 ,pp. : 71-77

Karger

Access to resources Recommend Favorite

Placotylene A, an Inhibitor of the Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Differentiation, from a Korean Sponge Placospongia sp.

By Kim Hiyoung   Kim Kwang-Jin   Yeon Jeong-Tae   Kim Seong Hwan   Won Dong Hwan   Choi Hyukjae   Nam Sang-Jip   Son Young-Jin   Kang Heonjoong  

Marine Drugs, Vol. 12, Iss. 4, 2014-04 ,pp. : 2054-2065

MDPI

Access to resources Recommend Favorite

Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways

By Shankar Eswar   Zhang Ailin   Franco Daniel   Gupta Sanjay  

Molecules, Vol. 22, Iss. 2, 2017-02 ,pp. : 264-264

MDPI

Access to resources Recommend Favorite

SRS06, a New Semisynthetic Andrographolide Derivative with Improved Anticancer Potency and Selectivity, Inhibits Nuclear Factor-κB Nuclear Binding in the A549 Non-Small Cell Lung Cancer Cell Line

By  

Pharmacology, Vol. 95, Iss. 1-2, 2015-01 ,pp. : 70-77

Karger

Access to resources Recommend Favorite

Effects of UVA and L-Ascorbic Acid on Nuclear Factor-κB in Melanocytes and in HaCaT Keratinocytes

By  

Skin Pharmacology and Physiology, Vol. 15, Iss. 5, 2002-09 ,pp. : 353-359

Karger

Access to resources Recommend Favorite